<DOC>
	<DOCNO>NCT00736840</DOCNO>
	<brief_summary>This trial pivotal trial validate use 13 C label substrate call methacetin BreathID automatic breath test system , determination cirrhosis patient chronic liver disease .</brief_summary>
	<brief_title>BreathID 13C-Methacetin Breath Test Detecting Cirrhosis</brief_title>
	<detailed_description>Patients chronic liver disease recent biopsy offer breath test . Correlation show histology breath test determine cirrhosis .</detailed_description>
	<mesh_term>Liver Diseases</mesh_term>
	<mesh_term>Fibrosis</mesh_term>
	<mesh_term>Liver Cirrhosis</mesh_term>
	<criteria>Age &gt; 18 chronic liver disease Patients take hepatotoxin drug . Patient severe congestive heart failure Patient severe pulmonary hypertension Patient uncontrolled diabetes mellitus Patient previous surgical bypass surgery morbid obesity Patient extensive small bowel resection Patient currently receive total parenteral nutrition Patient recipient organ transplant Patients receive antiviral treatment within past year Women pregnant Patient allergic acetaminophen ( Tylenol relate medication ) Patient history chronic obstructive pulmonary disease symptomatic bronchial asthma Patients unable sign inform consent Patients base opinion investigator enrol study Patients participate clinical trial evaluate experimental treatment procedure</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2012</verification_date>
	<keyword>Methacetin</keyword>
	<keyword>Breath</keyword>
	<keyword>Test</keyword>
	<keyword>Cirrhosis</keyword>
</DOC>